Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Insulin Human Articles

Lilly pulls out of inhaled insulin development

17 March 2008

Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%

4 February 2008

Pfizer's 1st-qtr profits tumble 17.5%

30 April 2007

Exubera shows safety and efficacy

7 February 2007

Exubera use not complicated by respiratory infections

25 September 2006

Emerging diabetes management solutions boost European market

14 August 2006

NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals

24 April 2006

Novo Nordisk's recombinant Velosulin OKed in USA

27 July 1999

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Italy's pharma market slump set to continue, warns GlobalData
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Italy's pharma market slump set to continue, warns GlobalData

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS